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Abstract: Activated macrophages which express somatostatin receptor-2 (SSTR-2) play a vital role in rupture of the 
vulnerable atherosclerotic plaques, which result in death. 68Ga-DOTATATE binds to somatostatin receptors 2, and 
therefore, can serve as potential radiotracer to detect atherosclerotic plaques. The purpose of this study was to gen-
erate preliminary data with this agent in vulnerable or fibrotic atherosclerotic plaques in the coronary arteries. We 
evaluated a total of 44 patients with neuroendocrine tumors (NET) who underwent 68Ga-DOTATATE PET/CT. In each 
subject, 7 segments in the coronary arteries were assessed, maximum SUV values and target-to-background ratios 
(TBRs) were calculated. The lesions detected by CT (a total of 308) were divided into 3 groups based on the Houn-
sfield unites (HU), and of which, 131 with HU less than 70 were classified as being normal (Control Group), 129 with 
HU 71-188 as fibrotic plaques (Group 2), and. 48 lesions with HU more than 188 as atherosclerotic plaques (Group 
3). The mean TBR value in the normal group was 1.345 ± 0.58 while the mean TBR value in the fibrotic plaque 
group was 1.752 ± 1.50 (p 0.0043) and in atherosclerotic plaques group was (2.043 ± 1.76, p<0.0001). There was 
a significant correlation (p=0.0026) between 68Ga-DOTATATE uptake and the progression to formation of atheroscle-
rotic plaques, based on HU. In patients with neuroendocrine tumors, 68Ga-DOTATATE PET/CT showed significantly 
increased uptake in the fibrotic and vulnerable atherosclerotic plaques compared to normal coronary arteries sug-
gesting a potential role of this tracer for molecular assessment of coronary artery disease in this population.
Keywords: Atherosclerotic plaques, 68Ga-DOTATATE, somatostatin receptor, cardiovascular risk factors, macro-
phage
Introduction
Cardiovascular disease is the leading cause of 
death in the United States and is responsible 
for almost one third of deaths in men and 
women worldwide [1, 2]. It is estimated that 61 
million people in the United States have cardio-
vascular disease [3]. More than 1 million Ame- 
ricans and more than 19 million individuals 
worldwide experience a cardiac event every 
year [4]. Rupture of a vulnerable atherosclerotic 
plaque is the major cause of cardiac event, 
which may lead to sudden death [5]. A vulnera-
ble plaque has large lipid core and thin fibrous 
cap infiltrated by macrophages. The accumula-
tion of activated macrophages in the vulnera-
ble atherosclerotic plaque eventually leads to 
the ruptures of plaques [6]. Metalloproteinases 
which are secreted by activated macrophages, 
will eventually rupture the fibrous cap leading to 
cardiac event [7, 8]. Several methods have 
been used to evaluate the atherosclerotic 
plaques including ultrasonography, CT, MRI, or 
angiography [9-11], but their role in detecting 
early disease and response to treatment is 
limited. 
As activated macrophages play an important 
role in forming and eventually rupturing of the 
vulnerable atherosclerotic plaques, imaging 
macrophages may provide a potential means 
for detecting and characterizing vulnerable ath-
68Ga-DOTATATE uptake in coronary artery plaques
66 Am J Nucl Med Mol Imaging 2015;5(1):65-71
erosclerotic plaques. It has been proven that 
activated macrophages overexpress soma-
tostatin receptor 2 (SSTR-2) [13-15]. By now, it 
has been shown that 68Ga-DOTATATE has affin-
ity for somatostatin receptors, including SSTR- 
2 and can be successfully used to image neuro-
endocrine tumors (NET). Therefore, this mole- 
cular imaging agent is being adopted as an 
effective tracer in clinical management for NET 
in multiple centers in US and EU [16-19]. 
Several studies have investigated the role of 
68Ga-DOTATATE PET/CT in assessment of mac-
rophages and a potential tracer to detect 
inflammatory process [20-22].
The purpose of this study was to assess the vul-
nerable atherosclerotic and fibrotic plaques in 
coronary arteries using 68Ga-DOTATATE PET/CT. 
We also examined the correlation between 
68Ga-DOTATATE uptake and known cardiovascu-




We retrospectively evaluated a total of 308 
lesions in the coronary arteries in the left main, 
LAD, LCX and RCA of the 44 patients with NET 
who underwent 68Ga-DOTATATE PET/CT from 
June 2013 through January 2014. The patients 
were examined with 68Ga-DOTATATE as an Inve- 
stigational New Drug (IND 117289) approved 
by the U.S. Food and Drug Administration (FDA), 
and BRANY Investigational Review Board (IRB). 
This study was also approved by the institution-
al review board and all subject signed an 
informed consent form before they were 
enrolled into this research study. All patients 
were histopathology proven with NET based on 
World Health Organization criteria for cancer 
[23]. The primary tumor sites were midgut, 
hindgut, bronchus and pancreas. The entire 
procedure was explained in detail to the 
patients and informed consent was obtained. 
None of the patients received steroids or had a 
recent history of inflammation or vasculitis. The 
cardiovascular risk factors including, hyperten-
sion, hyperlipidemia, smoking and diabetes 
were recorded for each subject. Also Body 
Mass Index (BMI) and history of prior cardiovas-
cular events were included in the data 
generated.
Patient population
For this analysis, we reviewed clinical and imag-
ing data of 44 patients of whom 23 were males 
(52%) and 21 were females (48%). All patients 
were proven to have neuroendocrine cancer by 
biopsy. Relevant baseline characteristics of the 
patients and detailed information regarding 
cardiovascular risk factors are reported in 
Table 1. 68Ga-DOTATATE uptake measurements 
in the coronary arteries proved to be feasible in 
all patients (100%). The lesions detected by CT 
(a total of 308) were divided into 3 groups 
based on the Hounsfield unites (HU), and of 
which, 131 with HU less than 70 were classified 
as being normal (Control Group), 129 with HU 
71-188 as fibrotic plaques (Group 2), and. 48 
lesions with HU more than188 as atheroscle-
rotic plaques (Group 3). 
Image acquisition
For 68Ga-DOTATATE PET, non gated images were 
acquired 60-90 minutes after injection of 130–
185 MBq (4-8mCi) of 68Ga-DOTATATE. PET 
Imaging were acquired from the top of the head 
to mid thighs, using a standard PET/CT scanner 
(Biograph 16, Siemens, Knoxville, TN, USA) in a 
3-dimensional mode (3 min per bed position) 
over an approximate 25-min scanning time. 
Low-dose CT without intravenous contrast was 
utilized for anatomic correlation and attenua-
tion correction. The CT kVp and mA exposure 
factors were determined based on the patient’s 
Table 1. Population Demographic
1. No. of Patients 44
2. Sex Male 23 (52.27%), Fe-
male 21 (47.73%)
3. Age (years) 59.84 (± 11.95)
4. Weight (lbs.) 175.91 (± 44.04)
5. Height (inch) 67.80 (± 3.45)
Risk Factors (%)
1. Prior Vascular Events 9.1





7. Family History of 
Hearth diseases
25.0
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body habitus. Patients on long-acting soma-
tostatin analogues were requested to cease 
these medications for at least 4 weeks prior to 
initiation of 68Ga-DOTATATE PET/CT imaging.
The 68Ge/68Ga generator (ITGmBH, Germany) 
was eluted with HCl by fractionated elution. The 
2 ml fraction with highest activity (8-22mCi) 
was added to the clinical kit of DOTATATE. The 
radiolabeling yield of reaction (%RCY) was 
determined by Instant Thin Layer Chroma- 
tography (iTLC) for QC validation after the final 
dose formulation. The activity of final 68Ga- 
DOTATATE dose administered to the patients 
was in the range of 4-8mCi. 
Interpretation of data
In each patient one segment in the left main 
and 2 proximal segments in each coronary 
artery including the left coronary artery, right 
coronary artery and left anterior descending 
artery were selected as target areas for the pur-
poses of this research study. Arterial calcifica-
tions were also assessed; vascular attenuation 
of >188 Hounsfield units was rated as calcified 
plaque and that of 77-188 was categorized as 
representing fibroid plaque [24, 25]. 
For PET data analysis, a region of interest (ROI)-
based approach was chosen. Maximal ‘stan-
dardized uptake values’ (SUVmax) for 68Ga- 
DOTATATE uptake was calculated for the seg-
ments described above. ROIs were placed in 
the segments noted above in coronary arteries 
and the Maximum SUV value was extracted for 
the final calculation of target-to-background 
ratios (TBRs). Background was defined as the 
average blood-pool uptake as determined by 
the mean SUV of two different ROIs (diameter 
of 1 cm) within the left ventricle. The SUVmax 
was divided by the mean blood-pool SUV in 
order to determine the TBR. We used the TBRs 
of all seven arterial segments for the final anal-
ysis. In each of these segments TBR value was 
correlated with Hounsfield units. We also cor-
related the uptake value and cardiovascular 
risk factor in all patients. For ROI assignment, 
visualization of PET/CT images, and SUV calcu-
lation, dedicated software (MIM Software Inc) 
was used.
Statistical analysis
Statistical analysis was performed using Prism 
(version 5.00; GraphPad Software) for Windows 
(Microsoft). Continuous variables with a normal 
distribution were recorded as mean ± standard 
deviation. An unpaired t-test was performed 
between the specified groups. Pearson correla-
tion coefficients were used for the assessment 
association between the uptake of the tracer 
(TBR) and the following cardiovascular risk fac-
tors: hypercholesterolemia, hypertension, smo- 
Figure 1. All lesions were divided into 3 groups based 
on their Hounsfield Units (HU). 130 target areas were 
classified in group 1 with HU <70 as normal. 129 le-
sions were categorized in group 2 with HU 71-188 
as fibrotic plaques and 48 lesions in group 3 with 
HU >188 were defined as atherosclotic plaques. The 
mean uptake value in group I, 2 and 3 was 1.345, 
1.751, and 2.043 respectively which proved to 
be statistically significant between group 1 and 2 
(p=0.0043) and group 1 and 3 (p<0.0001).
Figure 2. All patients were divided in 3 groups based 
on their lesion’s characteristics. The mean number 
of risk factors for normal, fibrotic and atherosclerotic 
plaque groups were 0.83, 3 and 4.22 respectively. 
One·way analysis of variance was performed in 3 
groups and showed statistically significant correla-
tion with the risk factors (p<0001).
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king, diabetes, family history, history of cardio-
vascular disease, age, and gender, as well as 
BMI.
Results
Atherosclerotic and fibrotic plaques uptake 
The mean TBR value was statistically higher in 
the fibrotic and atherosclerotic plaques groups 
compared to the normal group as shown in 
Figure 1. The mean TBR value in the normal 
group was 1.345 ± 0.58 while the mean TBR 
value in the fibrotic plaque group was 1.752 ± 
1.50 (p 0.0043). The atherosclerotic plaques 
group demonstrated higher TBR compared to 
the normal group (2.043 ± 1.76, p<0.0001) 
(Figure 1). We noted that fibrotic plaques, which 
are considered representing an early stage of 
atherosclerotic plaque formation, also showed 
higher uptake than normal group. There was a 
statistically significant correlation (p=0.0026) 
between 68Ga-DOTATATE uptake with the pro-
gression to formation of atherosclerotic pla- 
ques, based on HU. 
Correlation with risk factors
Atherosclerotic plaques are observed more in 
individuals with certain risk factors such as 
hypertension, hyperlipidemia, smoking, etc. To 
confirm whether the risk factors in the popula-
tion examined correlated with the TBR values 
generated, we analyzed our data accordingly. 
The most common risk factors in our patient 
population were hypertension, hyperlipidemia, 
smoking and family history of heart disease. 
Figure 2 shows the correlation between 
68Ga-DOTATATE TBR mean values and the num-
bers of cardiovascular risk factors. The mean 
number of risk factors in the normal group was 
0.83, while the mean number of risk factors 
increased to 3 in fibrotic plaque group, and to 
4.22 in atherosclerotic plaque group. One way 
analysis of variance was performed among 
these 3 groups and showed a statistically sig-
nificant P value (p<0.0001). Figure 3 shows 
correlation between the number of risk factors 
and target to background ratio of all lesions. 
We noticed that the patients with higher risk 
factors demonstrate higher 68Ga-DOTATATE up- 
take with TBR as demonstrated by rising curve 
in the Figure 3. The pearson regression showed 
this correlation to be significant (p=0.0068). 
Discussion
This research study aimed assessing the vul-
nerable atherosclerotic and fibrotic plaques in 
coronary arteries by using 68Ga-DOTATATE PET/
CT imaging. We also examined the correlation 
between 68Ga-DOTATATE uptake and the known 
cardiovascular risk factors in this population. 
68Ga-DOTATATE has also been shown to identify 
activated macrophages due to overexpression 
of the SSTR-2 [20]. SSTR-2 expression is upreg-
ulated in macrophages that migrate to the 
inflamed sites in the arteries while the normal 
endothelial cells lack these receptors.
We noted that there is higher uptake of 
68Ga-DOTATATE in atherosclerotic and fibrotic 
plaques in the coronary arteries likely due to 
the presence of activated macrophages in the 
plaques that express SSTR-2 receptors as seen 
in Figure 4. Li et al investigated the role 
68Ga-DOTATATE PET/CT for the detection of 
inflammation in the large arteries [21]. They 
found strong association of increased 
68Ga-DOTATATE uptake with known risk factors 
of cardiovascular disease in large arteries. 
Rominger et al. also found a significant correla-
tion between the presence of TBR and calcified 
plaque in the left anterior descending artery 
using 68Ga-DOTATATE PET/CT [22]. They also 
noted that the cut-off TBR value of greater than 
or equal to 1.5 gave an optimal threshold for 
specifically distinguishing between patients 
with and without coronary calcifications.
In our study in the high-risk group patients with 
higher risk factors, we found the value for TBR 
for 68Ga-DOTATATE to be significantly higher 
Figure 3. Correlation between the numbers of risk 
factors and target it background ration of all lesions. 
The analysis using Pearson regression showed P val-
ue to be statistically significant (p=0.0068).
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than those of patients with lower risk factors. 
Similar finding was observed in the study by Li 
et al. in which 68Ga-DOTATATE uptake correlat-
ed significantly with hypertension, age, and the 
presence of calcifications. They demonstrated 
that the risk factors for CAD correlated less 
strongly with foci of increased 18F-FDG uptake 
as compared to those of 68Ga-DOTATATE. This 
might be interpreted as an indication that 
68Ga-DOTATATE is more specific for the inflamed 
plaque.
It has also been demonstrated the SSTR-2 also 
plays a role in atherosclerotic plaques due to 
presence of angiogenesis which has been 
described in the context of unstable plaques 
[26]. A study by Adams et al. demonstrated a 
correlation between proliferation of the human 
umbilical vein endothelial cells and increased 
expression of SSTR-2 receptors, which sug-
gests an active role for this receptor in angio-
genesis. Therefore, 68Ga-DOTATATE PET/CT may 
be able to assess unstable plaques due to two 
different mechanisms: detection of inflamma-
tion as well as angiogenesis within the athero-
sclerotic lesion. 
The limitations of our study are the small sam-
ple size, non-gated image acquisition and lack 
of histological validation of 68Ga-DOTATATE 
uptake. Also, this study was performed in 
patients with cancer, and therefore, our find-
ings may be not generalized to a study popula-
tion of patients with well characterized coro-
nary artery disease. 
Conclusions
Our study demonstrate that in a series of 
patients with NET and atherosclerotic and fib- 
rotic plaques in coronary arteries, 68Ga- 
DOTATATE PET/CT shows significantly increased 
uptake compared to normal coronary arteries 
suggesting a potential role for this tracer in 
patients with coronary artery disease. Further 
studies are needed to evaluate the role of 
68Ga-DOTATATE PET/CT imaging in athero- 
sclerosis.
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